Crestline Management, LP Natera, Inc. Transaction History
Crestline Management, LP
- $1.88 Billion
- Q3 2024
A detailed history of Crestline Management, LP transactions in Natera, Inc. stock. As of the latest transaction made, Crestline Management, LP holds 66,485 shares of NTRA stock, worth $11.1 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
66,485
Previous 68,125
2.41%
Holding current value
$11.1 Million
Previous $7.38 Million
14.55%
% of portfolio
0.45%
Previous 0.58%
Shares
9 transactions
Others Institutions Holding NTRA
# of Institutions
526Shares Held
119MCall Options Held
308KPut Options Held
191K-
Vanguard Group Inc Valley Forge, PA11.4MShares$1.91 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.13 Billion0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY4.63MShares$775 Million0.05% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.56MShares$762 Million2.91% of portfolio
-
Fred Alger Management, LLC New York, NY4.01MShares$671 Million2.57% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $16.2B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...